TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
11.59
+0.08 (0.70%)
At close: Aug 13, 2025, 4:00 PM
10.10
-1.49 (-12.86%)
Pre-market: Aug 14, 2025, 8:38 AM EDT
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $9.66 million as of August 14, 2025. Its market cap has increased by 84.22% in one year.
Market Cap
9.66M
Enterprise Value
-1.91M
1-Year Change
84.22%
Ranking
Category
Stock Price
$11.59
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $9.66M, a decrease of -79.81%. That is a compound annual growth rate of -32.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 9.66M | 311.80% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |